Xiaode Feng
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- RNA modifications and cancer
- Cancer-related gene regulation
- Extracellular vesicles in disease
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 3
- Cancer-related gene regulation 2
- Surgery 6
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Co-authors
- Jian Wu (14 shared papers)Shusen Zheng (8 shared papers)Junru Chen (6 shared papers)Yunhao Chen (6 shared papers)Yuejie Lu (7 shared papers)Beng Yang (7 shared papers)Haiyang Xie (5 shared papers)Qiyang Cheng (4 shared papers)
- Journals
- Medicine (2 papers)International Journal of Biological Sciences (2 papers)Molecular Cancer (1 paper)Cell Death Discovery (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Xiaode Feng
17 papers receiving 872 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 403
- Molecular Biology 594
- Hepatology 27
- Pulmonary and Respiratory Medicine 101
- Oncology 84
Countries citing papers authored by Xiaode Feng
This map shows the geographic impact of Xiaode Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaode Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaode Feng more than expected).
Fields of papers citing papers by Xiaode Feng
This network shows the impact of papers produced by Xiaode Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaode Feng. The network helps show where Xiaode Feng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaode Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 208 | |
| 2 | 2020 | 172 | |
| 3 | 2020 | 150 | |
| 4 | 2021 | 61 | |
| 5 | 2019 | 54 | |
| 6 | 2019 | 48 | |
| 7 | 2018 | 41 | |
| 8 | 2019 | 28 | |
| 9 | 2019 | 27 | |
| 10 | 2023 | 20 | |
| 11 | 2020 | 18 | |
| 12 | Dimethyl fumarate suppresses hepatocellular carcinoma progression via activating SOCS3/JAK1/STAT3 signaling pathway. | 2019 | 16 |
| 13 | 2019 | 11 | |
| 14 | 2019 | 10 | |
| 15 | 2021 | 8 | |
| 16 | 2021 | 5 | |
| 17 | 2018 | 2 |
About Xiaode Feng
Xiaode Feng is a scholar working on Molecular Biology, Surgery, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 17 papers that have together received 879 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers), Cancer Mechanisms and Therapy (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Cancer-related gene regulation (2 papers), Cancer-related molecular mechanisms research (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Cancer Research (403 citations), Molecular Biology (594 citations), Hepatology (27 citations), Pulmonary and Respiratory Medicine (101 citations) and Oncology (84 citations). Xiaode Feng has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Jian Wu, Shusen Zheng, Junru Chen, Yunhao Chen, Yuejie Lu, Beng Yang, Haiyang Xie, Qiyang Cheng, Rongliang Tong and Chuanhui Peng. Their work appears in journals such as Medicine, International Journal of Biological Sciences, Molecular Cancer, Cell Death Discovery and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.